郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects.

期刊：European journal of pharmacology发表年份：2006作者：Francesco Gentili; Claudia Cardinaletti; Antonio Carrieri; Francesca Ghelfi; Laura Mattioli; Marina Perfumi; Cristian Vesprini; Maria Pigini
阅读更多 →

药效评价2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potency.

期刊：Journal of medicinal chemistry发表年份：2006作者：Alan D Borthwick; Dave E Davies; Anne M Exall; Richard J D Hatley; Jennifer A Hughes; Wendy R Irving; David G Livermore; Steve L Sollis; Fabrizio Nerozzi; Klara L Valko; Michael J Allen; Marion Perren; Shalia S Shabbir; Patrick M Woollard; Mark A Pri
阅读更多 →

药效评价Highly potent and selective phenylmorphan-based inverse agonists of the opioid delta receptor.

期刊：Journal of medicinal chemistry发表年份：2006作者：James B Thomas; Li Zhang; Hernan A Navarro; F Ivy Carroll
阅读更多 →

药效评价Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2006作者：Rosemarie Macion-Dazard; Nicholas Callahan; Zhen Xu; Nan Wu; Marc Thibonnier; Menachem Shoham
阅读更多 →